Subliminal Laser as Additional Therapy to Reduce Intravitreal Injection Number for the Patients with Macular Diseases

1. Lai T, Liu S, Das S, Lam D. Intravitreal Injections – Technique and Safety // Asia Pac J Ophthalmol, 2015; 4:321–328Search in Google Scholar

2. Falavarjani KG, Nguyen QD. Adverse events and complications associated with intravitreal injection of antiVEGF agents: a review of literature // Eye, 2013, 27(7):787–79410.1038/eye.2013.107370938523722722Search in Google Scholar

3. Spooner KL, Guinan G, Koller S, Hong T, Chang AA. Burden of Treatment Among Patients Undergoing Intravitreal Injections for Diabetic Oedema in Australia // Diabetes Metab Syndr Obes, 2019; 12:1931–1921Search in Google Scholar

4. Sii S, Aspinall P, Borooah S, Dhillon B. Exploring factors predicting changes in patients’ expectations and psychosocial issues during the course of treatment with intravitreal injections for wet age–related macular degeneration // Eye, 2017, 32(4):673–67810.1038/eye.2017.271589885629219960Search in Google Scholar

5. Wu Y, Ai P, Ai Z, Xu G. Subthreshold diode micropulse laser versus conventional laser photocoagulation monotherapy or combined with antiVEGF therapy for diabetic macular edema: A Bayesian network meta–analysis // Biomed Pharmacother, 2018, (97):293–29910.1016/j.biopha.2017.10.07829091878Search in Google Scholar

6. Akhlaghi M, Dehghani A et al. Effects of subthreshold diode micropulse laser photocoagulation on treating patients with refractory diabetic macular edema // J Curr Ophthalmology, 2018, 31(2): 157–16010.1016/j.joco.2018.11.006661192331317093Search in Google Scholar

7. Gonzales–Saldivar G, Rojas–Juarez S, Espinosa–Soto I et al. Single–Spot Yellow Laser Versus Conventional Green Laser on Panretinal Photocoagulation: Patient PAin Scores and Preferences // Ophthalmic Surg Lasers Imaging Retina, 2017, 48(11):902–90510.3928/23258160-20171030-0529121359Search in Google Scholar

8. Parodi M B, Iacono P, Bandello F. Subthreshold grid laser versus intravitreal bevacizumab as a second line therapy for macular edema in branch retinal vein occlusion recurring after conventional grid laser treatment // Graefes Arch Clin Exp Ophthalmol, 2015, (10):1647–165110.1007/s00417-014-2845-625382074Search in Google Scholar

9. Lim LS, Cheung CMG, Mitchell P, Wong TY. Emerging evidence concerning systemic safety of anti–VEGF agents – should ophthalmologists be concerned? // Am J Ophthalmol, 2011 152(3): 329–3310.1016/j.ajo.2011.05.04021855670Search in Google Scholar